REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
04/21/2025
Back to search
Official data from USPTO
M-PIMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
M-PIMA
ST13
US500000079239079Class
5, 9, 10
Filing
79239079
Registration
6035854
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
38
Latest update
04/22/2025
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 10
Filing date
06/14/2018
Registration date
04/21/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2020
Last transaction
04/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
IE
Examiner
BEVERLY, JOSETTE
Law office
M60
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Abbott Rapid Diagnostics International Unlimited Company
Abbott Rapid Diagnostics International Holdco Unlimited Company
Alere Switzerland GmbH
Representatives
Michele H. Bowman Abbott Laboratories
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Medical diagnostic reagents; testing preparations for medical use, namely, cartridges pre-filled with dried formulated assay reagents, process controls, and buffers, for molecular diagnostic testing of bodily fluids and tissue for HIV diagnosis, HIV viral load, and Filovirus; molecular diagnostic tests for medical use for detecting and managing infectious diseases; diagnostic tests for medical use in the form of cartridges for measuring amounts of viruses; diagnostic tests for medical use in the form of cartridges for detecting infectious diseases; medical reagents contained in a cartridge for medical diagnostic use; in vitro diagnostic reagents contained in pre-filled cartridges for medical use; molecular diagnostic assays; medical diagnostic assays for testing of bodily fluids and tissue to detect and manage infectious diseases
Class 9
Computer hardware and software for use in medical testing and analysis of blood, bodily fluid and tissue; software for use in molecular diagnostic medical testing and analysis; software in the field of medical diagnostics for use in detecting and managing infectious diseases; computer operating software for laboratory instruments; computer software for diagnosing human diseases; laboratory instruments, namely, molecular diagnostic testing instruments that test for the presence of HIV and Filovirus, not for medical purposes; laboratory diagnostic analyzers for molecular diagnostic testing; laboratory molecular analyzers for use in molecular diagnostic medical testing and analysis
Class 10
Medical diagnostic instruments and parts therefore for molecular diagnostic analysis; medical diagnostic analyzers and parts therefore for detecting and managing infectious diseases; medical apparatus for determining and analyzing in vitro molecular interactions; medical apparatus for analyzing molecules, cells, tissues and organisms for detecting and managing infectious diseases; medical apparatus for analyzing nucleic acid and proteins for diagnosis and testing of infectious diseases; medical instruments used for blood, bodily fluid and tissue testing; nucleic acid medical testing instruments for diagnosis and management of infectious diseases; medical diagnostic instruments for detection of infectious diseases; pre-filled cartridges for detecting and managing infectious diseases
Publications
History of USPTO decisions and trademark events.
38 publications found
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/20/2024
CHLD
CHANGE OF OWNER RECEIVED FROM IB
03/27/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/26/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
09/05/2020
FIMP
FINAL DISPOSITION PROCESSED
08/27/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/21/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
02/14/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/04/2020
PUBO
PUBLISHED FOR OPPOSITION
02/04/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/31/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/29/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
01/29/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/15/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/15/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/15/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/30/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/04/2019
GNRT
NON-FINAL ACTION E-MAILED
06/04/2019
CNRT
NON-FINAL ACTION WRITTEN
06/04/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/30/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/29/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/29/2019
RFNT
REFUSAL PROCESSED BY IB
11/17/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/15/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/29/2018
RFRR
REFUSAL PROCESSED BY MPU
10/29/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/16/2018
CNRT
NON-FINAL ACTION WRITTEN
10/15/2018
DOCK
ASSIGNED TO EXAMINER
09/30/2018
MAFR
APPLICATION FILING RECEIPT MAILED
08/28/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/24/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/23/2018
Continuous trademark protection
Get notified about every new filing that threatens M-PIMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.